Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Berneman

Showing results (121-130 of 219) with videos related to

Pageof 22
Sort By:
Leukemia|August 27, 2005
Antigen-specific cellular immunotherapy of leukemiaA Van Driessche, L Gao, H J Stauss, et al.
Annals of Hematology|March 10, 2001
Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cellsR Willems, E Henckaerts, M Lenjou, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer ImmunotherapyEvelien L J M Smits, Barbara Stein, Griet Nijs, et al.
Blood|June 22, 2001
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cellsV F Van Tendeloo, P Ponsaerts, F Lardon, et al.
Toxicology Letters|March 15, 2005
Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritantsAnn C A De Smedt, Rosette L Van Den Heuvel, Vigor F I Van Tendeloo, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2009
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cellsEvelien L J M Smits, Nathalie Cools, Eva Lion, et al.
Journal of Virology|December 1, 1995
Identification of human telomeric repeat motifs at the genome termini of human herpesvirus 7: structural analysis and heterogeneityP Secchiero, J Nicholas, H Deng, et al.
Journal of Translational Medicine|March 15, 2022
Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cellsGils Roex, Diana Campillo-Davo, Donovan Flumens, et al.
The Journal of Experimental Medicine|September 1, 1994
Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cellsH W Snoeck, D R Van Bockstaele, G Nys, et al.
In Vivo (Athens, Greece)|July 1, 1994
Ampligen inhibits human herpesvirus-6 in vitroD V Ablashi, Z N Berneman, M Williams, et al.
Pageof 22

Showing results (121-130 of 219) with videos related to

Sort By:
Pageof 22
Leukemia|August 27, 2005
Antigen-specific cellular immunotherapy of leukemiaA Van Driessche, L Gao, H J Stauss, et al.
Annals of Hematology|March 10, 2001
Establishment of serum-free pre-colony forming unit assays for differentiation of primitive hematopoietic progenitors: serum induces early macrophage differentiation and inhibits early erythroid differentiation of CD34++CD38- cellsR Willems, E Henckaerts, M Lenjou, et al.
Methods in Molecular Biology (Clifton, N.J.)|April 2, 2016
Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer ImmunotherapyEvelien L J M Smits, Barbara Stein, Griet Nijs, et al.
Blood|June 22, 2001
Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cellsV F Van Tendeloo, P Ponsaerts, F Lardon, et al.
Toxicology Letters|March 15, 2005
Capacity of CD34+ progenitor-derived dendritic cells to distinguish between sensitizers and irritantsAnn C A De Smedt, Rosette L Van Den Heuvel, Vigor F I Van Tendeloo, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2009
The Toll-like receptor 7/8 agonist resiquimod greatly increases the immunostimulatory capacity of human acute myeloid leukemia cellsEvelien L J M Smits, Nathalie Cools, Eva Lion, et al.
Journal of Virology|December 1, 1995
Identification of human telomeric repeat motifs at the genome termini of human herpesvirus 7: structural analysis and heterogeneityP Secchiero, J Nicholas, H Deng, et al.
Journal of Translational Medicine|March 15, 2022
Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cellsGils Roex, Diana Campillo-Davo, Donovan Flumens, et al.
The Journal of Experimental Medicine|September 1, 1994
Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cellsH W Snoeck, D R Van Bockstaele, G Nys, et al.
In Vivo (Athens, Greece)|July 1, 1994
Ampligen inhibits human herpesvirus-6 in vitroD V Ablashi, Z N Berneman, M Williams, et al.
Pageof 22